Week In Review: Week's China Life Science Investments Total $800 Million
December 19, 2020 at 12:23 PM EST
Harbour BioMed completed a $221 million Hong Kong IPO to continue its novel drug development. Singlera Genomics, a San Diego-Shanghai genomics testing company, closed a $150 million Series B financing from China investors.